Unboosted Atazanavir as Initial ART Therapy in China

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01459575
Recruitment Status : Completed
First Posted : October 25, 2011
Last Update Posted : October 25, 2011
BMS company
Information provided by (Responsible Party):
NCAIDS, National Center for AIDS/STD Control and Prevention, China CDC

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2005
  Actual Study Completion Date : December 2006